while VEGF-A treatment of AD hippocampal neurons cultures, by regularizing VEGFR-2 signaling, partly recovers the Aβ-induced variations of dendritic spine morphology and density impairments [72]. The gene discussed is KDR; the disease is Alzheimer disease.